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Abstract
Long interspersed (L1) and Alu elements are actively amplified in the human genome through retrotransposition of their
RNA intermediates by the ,100 still retrotranspositionally fully competent L1 elements. Retrotransposition can cause
inherited disease if such an element is inserted near or within a functional gene. Using direct cDNA sequencing as the
primary assay for comprehensive NF1 mutation analysis, we uncovered in 18 unrelated index patients splicing alterations
not readily explained at the genomic level by an underlying point-mutation or deletion. Improved PCR protocols avoiding
allelic drop-out of the mutant alleles uncovered insertions of fourteen Alu elements, three L1 elements, and one poly(T)
stretch to cause these splicing defects. Taken together, the 18 pathogenic L1 endonuclease-mediated de novo insertions
represent the largest number of this type of mutations characterized in a single human gene. Our findings show that
retrotransposon insertions account for as many as ,0.4% of all NF1 mutations. Since altered splicing was the main effect of
the inserted elements, the current finding was facilitated by the use of RNA–based mutation analysis protocols, resulting in
improved detection compared to gDNA–based approaches. Six different insertions clustered in a relatively small 1.5-kb
region (NF1 exons 21(16)–23(18)) within the 280-kb NF1 gene. Furthermore, three different specific integration sites, one of
them located in this cluster region, were each used twice, i.e. NM_000267.3(NF1):c.1642-1_1642 in intron 14(10c),
NM_000267.3(NF1):c.2835_2836 in exon 21(16), and NM_000267.3(NF1):c.4319_4320 in exon 33(25). Identification of three
loci that each served twice as integration site for independent retrotransposition events as well as 1.5-kb cluster region
harboring six independent insertions supports the notion of non-random insertion of retrotransposons in the human
genome. Currently, little is known about which features make sites particularly vulnerable to L1 EN-mediated insertions. The
here identified integration sites may serve to elucidate these features in future studies.
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Introduction
Long interspersed nuclear elements (LINE-1 or L1 elements)
and Alu sequences belonging to the family of short interspersed
nuclear elements (SINEs) still actively amplify in the human
genome, by a process called retrotransposition. L1 elements
comprise ,17% of the human genome sequence [1] but of the
,500.000 L1 copies only ,80–100 are still fully capable of active
retrotransposition [2]. Equally, only a small minority of the .1
million Alu elements comprising more than 10% of the human
genome can retrotranspose in a non-autonomous process, using
proteins encoded by L1 elements to mediate their mobility [3].
The active Alu elements are named master or source Alu elements [4–
5]. L1 elements are transcribed by RNA polymerase II whereas
polymerase III transcribes Alu elements. Both elements are
transcribed from an internal promoter [6–7]. While L1 transcripts
are polyadenylated after transcription, the poly(A) tail of Alu
transcripts may be encoded directly from the genomic site of
transcription [8]. Alu transcripts are then terminated at the 39 end
with a short run of U’s [8]. L1 elements are autonomous
retrotransposons. Active L1 elements are typically 6 kb in length
and contain two non-overlapping open reading frames ORF1 and
ORF2 [9–10]. The latter encodes a protein with endonuclease (L1
EN) and reverse transcriptase (L1 RT) activities [11–12]. It is
generally accepted that L1 EN forms a nick at the insertion site of
L1 elements and the L1 transcripts are reverse transcribed using
the 39 overhang of the nick as a primer [11]. The consensus
cleavage site of L1 EN 39-AA/TTTT-59 (and derivates thereof)
[11,13] which usually cleaves at the bottom strand allows the T’s
at the 39 terminus of the nick to prime reverse transcription from
the poly(A) end of a L1 transcript. There is evidence that Alu
elements are reverse transcribed by the same process called ‘‘target
primed reverse transcription’’ (TPRT), but they need to ‘‘borrow’’
the factors for TPRT from L1 elements [14] and are, hence, called
non-autonomous retrotransposons. Integration of the generated
cDNA is less well understood. Generally, cleavage of the second
DNA strand occurs a few base pairs (typically 7–20 bp)
downstream of the first nick, causing target site duplications
(TSD) and the free 39 end at the second cleavage site is used to
prime the second strand cDNA synthesis. The whole process
results in the formation of a new DNA copy of an L1 or Alu
element including the poly(A) tail flanked by short direct repeats of
PLoS Genetics | www.plosgenetics.org 1 November 2011 | Volume 7 | Issue 11 | e1002371the duplicated target site. For a detailed description of the
mechanisms of autonomous and non-autonomous retrotransposi-
tion see [8,15] and papers cited therein.
Although retrotransposable elements have no immediate
function in the cell, their motility can be important for genome
plasticity and the creation of genetic variation [16]. Most recent
studies [17–20] demonstrate that L1 and Alu elements dimorphic
with respect to presence/absence at a given site contribute
significantly to structural variation of the human genome.
Furthermore, these studies show that current activity of mobile
elements is likely to be higher than previously appreciated.
L1 and Alu elements are believed to insert randomly into the
human genome. Hence, de novo transposition of an element may
occasionally cause an inherited disease when the element is
inserted into (or at proximity of) the coding region of a functional
gene [21]. To date, only ,65 cases of de novo L1 EN-mediated
insertions of retrotransposable elements causing genetic diseases
have been reported [22–23]. A systematic analysis of retrotrans-
positional events causing genetic disorders lists 48 such mutations
consisting of 26 Alu, 15 L1, four SINE/VNTR/Alu (SVA)
composite element insertions as well as three simple poly(A)
insertions [24]. These de novo insertions were found in 31 different
genes including one insertion in the NF1 gene [25]. It has long
been suspected that L1 EN-mediated retrotranspositional events
are underreported as disease causing mutations, since they may be
overlooked by the most commonly used mutation detection
methods that rely on PCR amplification of small amplicons, i.e.
exons from genomic DNA [26] (and reviewed later on in [27–28]).
Here we report 18 novel L1 EN-mediated insertions in the NF1
gene: one poly(T), three L1 and 14 Alu insertions were all
identified using an RNA-based core assay as the starting point for
comprehensive NF1-gene analysis illustrating the strength of this
approach in identifying also this complex type of mutations. Of
note, six of the integration sites were located within a relatively
small genomic region of 1500 bp between NF1 exons 21 (16) and
23 (18) (exons are numbered consecutively according to the NCBI
reference sequence NM_000267.3; in addition, the more widely
known historical legacy numbers, originally designated by the
international NF1 consortium, are given in parentheses). Even
more striking, three of the integration sites within the NF1 gene
were used twice. Our results indicate and confirm that some
genomic locations may be especially prone to L1 EN mediated
retrotransposition.
Results
Identification of 18 L1 EN-dependent de novo insertions
into the NF1 gene
Direct cDNA sequencing used as the core assay of comprehen-
sive NF1 mutation analysis in the two centers (UAB and MUI)
uncovered heterozygous (,50% of the transcripts affected) splicing
alterations in 18 NF1 index patients (Table 1) that could neither be
explained by a heterozygous mutation of the splice regulatory
elements of the affected exon and/or the flanking intronic
sequences nor by a deletion of the genomic DNA. However,
fragment analysis of the gDNA amplicons of the affected exons
showed in some cases a faint extra band of larger size absent in the
PCR products of a control DNA (Figure S2A). Sequence analysis
of these PCR products revealed a faint additional sequence,
besides the wild type sequence, starting at the position where the
retroelement was inserted (Figure S2B). Manual reading of the
background sequences revealed the presence of Alu elements
inserted within the exonic sequences. In addition to the
approximately 280-bp long Alu elements a 60–120-bp long poly(A)
tail -or a poly(T) tail- was inserted depending on whether the Alu
element was inserted in the sense or antisense orientation with
respect to the NF1 reading frame (Figure S2B). As expected for de
novo retrotransposed Alu elements the inserted sequences were
flanked by short duplicated sequences derived from the insertion
sites, i.e. target site duplication (TSD). We reasoned that the
substantial increase in size of the mutant exons containing the Alu/
L1 insertions, compared to the wild type exons caused allelic drop-
out under standard PCR conditions. We increased the extension
time of the PCR reactions and/or increased the size of the PCR
amplicons to enhance the amplification of the larger mutant alleles
and, hence, facilitate the detection of possible de novo Alu insertions.
Amplification of all exons with so far unexplained splicing
alterations using PCR conditions optimized to amplify larger
PCR products (Figure 1A and 1B) led to the identification of 14
different de novo Alu insertions (Table 1) as well as an approximately
120-bp poly(T) stretch in exon 25 (19b) resulting in skipping of the
last 40 nucleotides of this exon in the mRNA transcripts.
To further confirm the presence of the Alu elements within the
mutant NF1 alleles and to determine precisely the inserted
sequence, the PCR products showing the extra bands of increased
size were cloned and sequenced (Figure 1B). Additionally or
alternatively, Alu-insertion-specific primers were used together
with the regular exon primer at the opposite site of the exon to
specifically amplify and subsequently sequence the mutant alleles
(Figure S3). All 14 Alu insertions identified are listed in Table 1.
Alignment of the inserted Alu sequences with the consensus
sequence of the different Alu families (as deposited in Repbase Giri
[29]) showed that two Alu elements belong to the AluY, six to the
AluYa5 and six to the AluYb8 family (Figure S4). Three of the Alu
insertions were truncated and lacked at their 59 end 17, 20 and 39-
bp, respectively, (see patients MUI-2, UAB-R07118 and UAB-
R869001 in Figure S4). Six of the Alu elements were inserted in
sense and eight in anti-sense orientation.
Increase of the amplicon size and the PCR extension time of
exons 39 (30), 23 (18) and 9 (7) did not allow resolution of the
Author Summary
Repetitive retrotransposable elements, including LINE1
and Alu elements accounting for more than one fourth
of the human genome, are still actively amplifying. It is
widely believed that retroelements insert randomly in the
genome. Retroelements newly inserted in the germ line
may cause genetic disease, if a functional gene is
disrupted. Up to now, only ,65 well-characterized
pathogenic retroelement insertions in 31 different human
genes have been reported. Therefore, retrotransposition is
suspected to be underdiagnosed as disease-causing
mutation mechanism. Reporting 18 novel insertions in
the NF1 gene, all identified by a comprehensive RNA–
based mutation analysis protocol, we show that L1 and Alu
insertions represent 0.4% of all NF1 mutations. Strikingly,
we found three integration sites within this 280-kb gene
that were used twice independently to insert a retro-
element. One of these sites was located in a 1.5-kb
‘‘hotspot’’ region where four additional integration sites
clustered. These findings, together with three additional
integration sites used multiple times independently to
insert retroelements in other genes, indicate that some
genomic sites may be especially prone to host newly
retrotransposed elements. As some of these sites are
embedded in ‘‘hotspot’’ regions, larger flanking sequences
may play a role in making these sites particularly
vulnerable.
Hotspots for Retroelement Insertions in NF1 Gene
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R316001 and UAB-R91409, respectively. Use of a Taq polymer-
ase enabling amplification of extremely long PCR products (up to
.6 kb) was needed to amplify the mutant exons which had 10-
and 17-times increased in size compared to their wild type normal
allele in patients UAB-R316001 and UAB-R01429, respectively. A
6-kb full-length L1 element inserted in sense orientation into exon
39 (30) was identified in patient UAB-R01429 (Figure 2A). Full
sequencing of the inserted L1 element showed it to belong to the
youngest L1 (Ta-1d) subset since it carried all sequence variants
that distinguish this L1 (Ta) group from others [2,30]. It contained
10 deviations from the consensus sequence of hot L1 sequences as
given by [2] (Figure S5). Sequence alignment with all known intact
L1s of the Ta-1d subset [31] showed that the closest related hot L1
(Ta-1d) element is contained in NCBI sequence AL356438. Only
six nucleotides differentiate the full-length L1 identified in exon 39
(30) from this possible precursor sequence. A 59-truncated L1
element was found to be inserted in sense into exon 23 (18) in
patient UAB-R316001. The latter sequence contained 1753 bp of
the 39-half of ORF2 and the poly(A) tail but lacked the ORF1 and
the promoter region of L1 elements. Furthermore, it was preceded
by a short 8-bp sequence neither derived from the target sequence
nor from the inserted L1 element, a finding that previously has
been observed for L1 retrotransposition events in cultured cells
[32–34]. This L1 element belongs to the L1(pre-Ta) subset since it
carries a 3-bp ACG at the site discriminating the L1(Ta) and
L1(pre-Ta) subsets [35]. In intron 9 (7) we found a sequence
inserted that contained a poly(T) stretch at the 59-end indicating
that the poly(A) tail of the inserted retrotransposon transcript had
annealed to the sense strand where reverse transcription from the
template started. Sequencing from the reverse strand showed,
however, that the 39-end of the inserted sequence contained part
of an L1 ORF2 sequence (see Figure S6). This sequence was
inserted in sense orientation with regard to the NF1 coding
sequence suggesting that during the process of retrotransposition
the orientation of the reverse transcription from the L1-RNA
template that started at the sense strand of the NF1 gene switched
and continued from the anti-sense strand. Due to experimental
difficulties and lack of sufficient patient’s DNA it was not possible
to assess the full sequence of the inserted L1 element and,
therefore, the breakpoint of inversion could not be defined.
Analysis of insertion sites
Alignment of the sequences at the integration sites (Table 2)
shows that all integration sites match the reported L1 EN
consensus cleavage site [13], indicating that all insertions arose
via L1 EN-mediated retrotransposition. The exact insertion site of
an AluY element into intron 10 (8) cannot be determined due to a
71-bp deletion associated with this insertion that causes also lack of
a TSD. Nevertheless, the most likely insertion site matching a L1
EN cleavage site is tentatively given in Table 2. The alignment of
the integration sites also shows that the 18 retroelements inserted
in 15 different integration sites with three of them used twice
independently. We found in two non-related patients (UAB-
R10408 and UAB-R164201 in Table 1) an AluY and AluYb8
element inserted into the splice acceptor site of intron 14 (10c).
The same L1 EN cleavage site was used once at the anti-sense
strand to insert the AluY element in sense orientation with respect
to the coding sequence of the NF1 gene (integration site according
to HGVS nomenclature c.1642-1_1642) and in an unrelated
patient once at the sense strand to insert the AluYb8 element in
anti-sense orientation (integration site according HGVS nomen-
clature c.1642-12_1642-11). Furthermore, we found in two non-
related patients (UAB-R81017 and UAB-R340101 in Table 1) an
AluYa5 and an AluYb8 element, respectively, inserted at the
identical integration site, c.4319_4320, in exon 33 (25). Both Alu
elements were inserted in sense orientation and flanked by the
same sized TSD (Table 2). Finally, in two non-related patients
(UAB-R37616 and UAB-R37305 in Table 1) -one of them being a
sporadic patient proven to have a de novo insertion- an AluYa5
element inserted at the identical position, c.2835_2836, in exon 21
(16). The length of TSDs flanking the two insertions differed
between both patients (Table 2) confirming further that two
independent events led to the formation of these two mutant
alleles. This site was located within a 1.5-kb genomic region
containing exons 21 (16), 22 (17) and 23 (18) that harbor a total of
six independent retrotranspositions. The remaining eight integra-
tion sites of de novo insertions were distributed over the entire NF1
gene from exon 6 (4c) to intron 48 (39).
Different splicing effects are associated with de novo Alu
and L1 insertions
Four out of 14 Alu elements (UAB-R10408, UAB-R164201,
UAB-R07118 and UAB-R119201 in Table 1) were inserted into
the canonical AG-dinucleotide (1/4) or the polypyrimidine tract
(3/4) of the 39 splice sites of introns 14 (10c), 48 (39), and 10 (8),
respectively. Disruption of these splice sites readily explains the
observed skipping of the downstream exons (type 1 splicing effect
in Figure 3). Skipping of the affected exon was also observed in five
other patients with Alu insertions, i.e. two insertions at the identical
site in exon 33 (25), two insertions at different integration sites in
exon 22 (17) and one insertion in exon 6 (4c) (type 2 effect in
Figure 3). Two AluYa5 elements (UAB-R37305 and UAB-R37616
in Table 1) inserted at the identical integration site c.2835_2836 in
exon 21 (16) in two unrelated patients causing skipping of the last
233 nucleotides of this 441-bp exon. This partial exon skipping
results from the use of a cryptic 59 splice site located upstream of
the integration site (type 3 effect in Figure 3). Similarly, integration
of an AluYb8 element at position c.2439_2440 in the 59 half of
exon 21 (16), 30 nucleotides downstream of the intron-exon 21 (16)
border, resulted in the use of a cryptic 39 splice site downstream of
the integration site and loss of the first 229 bp of the exon 21 (16)
(mutation UAB-R39428 in Table 1; type 4 effect in Figure 3).
Insertion of the approximately 120-bp poly(T) stretch at
c.3312_3313 in exon 25 (19b), 3 nucleotides upstream of the
exon-intron border also led to use of a cryptic 59 splice site and loss
of the last 40 nucleotides of this exon (mutation UAB-R75103;
type 3 effect in Figure 3). Insertion of an AluYa5 element into exon
47 (38) resulted in at least two different splicing effects, i.e. skipping
of the exon and use of an exonic cryptic 59 splice site upstream of
the integration site (mutation MUI-2; type 2 and 3 splicing effect
in Figure 3; see also Figure S1). Insertion of an AluYb8 element
into exon 12 (10a) also resulted in a more complex splicing defect.
This element lacks the first 39 bp at its 59 end (UAB-R869001 in
Table 1 and Figure S4). A cryptic 59 splice site within this
truncated Alu element is used instead of the natural one of the exon
12 (10a), leading to transcripts containing the first 61 nucleotides
of this Alu element but lacking the 39 half of exon 12 (10a),
downstream of the Alu integration site (type 5 effect in Figure 3).
Insertion of the 59-truncated L1 element into exon 23 (18) also
caused simple exon skipping in the transcripts of the patient UAB-
R316001 (type 2 splicing effect in Figure 3). The insertion of the
59-inverted L1 element 195 nucleotides downstream of exon 9 (7)
caused skipping of exon 9 (7) as well as inclusion of a 130-bp
cryptic exon embedded within the inserted L1 element (patient
UAB-R91409; type 6 effect in Figure 3; see also Figure S6).
Finally, a 59 splice site within the full-length L1 element inserted
into exon 39 (30) is used instead of the natural 59 splice site of exon
Hotspots for Retroelement Insertions in NF1 Gene
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exon downstream of the integration site and containing instead the
first 96 nucleotides of the L1 element (patient UAB-R01429; type
5 effect in Figure 3).
Taken together, all Alu and L1 elements as well as the insertion
of a poly(T) element lead to altered splicing of the transcripts from
the mutant allele. None of the inserted Alu or L1 elements was fully
included into the transcripts.
Discussion
Here we report the identification of 18 pathogenic L1 EN-
mediated insertions into the NF1 gene. This is the largest number
of disease causing mutations of this type found in a single human
gene. Sixteen of these insertions were found in a cohort of 4300
unrelated NF1 mutation-positive patients analyzed at UAB and
two in a cohort of 200 unrelated NF1 mutation-positive patients
analyzed at MUI. Taken together, this suggests that retro-
transposon insertions account for ,0.4% (18/4500) of NF1
mutations identified. This frequency is two to four times higher
than previously anticipated [36] and expected from a database
survey in human genetic diseases [28]. Two mutually non-
exclusive explanations for this observation may be taken in
consideration.
Improved detection of L1 EN-mediated de novo
insertions by NF1 cDNA sequencing
Firstly, mutations due to retrotransposition have long been
thought to be underestimated, since they may be missed by
mutation detection methods relying on PCR amplification of small
amplicons, i.e. exons, from genomic DNA [26–28] and references
cited therein. Indeed, all insertions reported here were identified
because they altered splicing of the transcripts as detected by direct
cDNA sequencing [37]. In order to identify the cause of the
splicing defects, i.e. the Alu, L1 and poly(T) stretch insertions, it
was necessary in most of the cases to modify the PCR conditions to
prevent allelic drop-out of the substantially larger mutant allele.
Hence, most of these mutant alleles would be missed by an exon
by exon-sequencing approach. Similar findings were reported for
the BRCA1 and BRCA2 genes [38] and even for genes involved in
X-linked diseases [39] although allelic drop-out is expected to be
less severe in X-linked diseases due to hemizygosity of the mutant
allele in the affected males. Thus, our results demonstrate that
RNA-based mutation analysis protocols are more apt to uncover
L1 EN-mediated retrotransposon insertions.
The NF1 gene may be a preferred target of
retrotransposon integration in the human genome
Secondly, it is possible that the NF1 gene is particularly
susceptible to retrotransposon integration. It is striking that three
specific sites within the NF1 exons 21 (16) and 33 (25) and the
splice acceptor site of intron 14 (10c) hosted each two
independently retrotransposed elements. Moreover, one of these
sites is located in a small region of approximately 1.5 kb within the
,280-kb NF1 gene where six of the 18 insertions cluster.
Together, these finding strongly support the notion of an non-
random de novo insertion of retrotransposons in the human genome
[24]. A systematic analysis of 48 previously reported simple L1
EN-dependent insertions showed that some genes, e.g. F8 and F9
mutated in hemophilia B, may have hotspot regions for retro-
Figure 1. Example of de novo Alu insertion detection by improved PCR conditions. A) Agarose gel with PCR products of exon 6 (4c)
generated with two different primer pairs and PCR conditions generating a 403-bp (short) and a 904-bp (long) wild type PCR product (see Table S1).
PCR products were generated from a control individual (C) and the patient (P) harboring an AluYa5 insertion in exon 6 (4c) (W=water control).
Amplification of the large PCR product from the patient revealed the presence of extra bands of increased size, i.e. a ,1200-bp band representing the
homoduplex of the PCR product from the mutant allele and two larger bands probably derived from heteroduplexes of this PCR product with the
PCR product from the wild type allele, which are neither present in the control nor in the shorter amplified PCR products. (B) Sequences of the short
and long PCR products from the control individual and the patient; the sequence of the long PCR product but not of the short PCR product of the
patient shows starting at nucleotide position c.651 (vertical dotted line) a background sequence coming from the inserted AluYa5 element (see
scheme below the sequences). The sequence of a cloned long PCR product clearly shows the presence of the AluYa5 element within the NF1 exon 6
(4c).
doi:10.1371/journal.pgen.1002371.g001
Hotspots for Retroelement Insertions in NF1 Gene
PLoS Genetics | www.plosgenetics.org 5 November 2011 | Volume 7 | Issue 11 | e1002371Figure 2. Amplification of the mutant allele containing a full-length L1 element inserted into exon 39 (30). (A) Agarose gel with PCR
products of exon 39 (30) generated with two different PCR conditions. PCR products were generated from a control individual (C) and the patient (P)
harboring a full-length L1 element in exon 39 (30) (W=water control). The PCR conditions (short) used in the diagnostic laboratory generate only the
359-bp product from the wild type allele present in the control and the patient, whereas a .6000-bp PCR product derived from the mutant allele was
amplified along with the wild type 359-bp PCR product using the Expand Long Template PCR system kit (Roche), buffer system 2 and 3 (long) (see
Table S1). (B) Sequences of the PCR products from the patient generated with the PCR conditions ‘‘short’’ and ‘‘long’’; the sequence of the long PCR
product but not of the short PCR product of the patient shows starting at nucleotide position c.5607 (vertical dotted line), besides the main wild type
sequence, minor traces of a sequence coming from the inserted L1 element (see scheme below the sequences). The presence of the L1 element
within the NF1 exon 39 (30) was confirmed using a L1-specific PCR (primers: 39f and L1-5_39r). The entire 6021-bp sequence of this L1 (Ta-1d)
element is deposited in Figure S5.
doi:10.1371/journal.pgen.1002371.g002
Table 2. Sequences at the integration sites aligned to the L1 endonuclease cleavage consensus site.
Integration sites TSD Orientation Alu family NF1 location
39AAAGAGAAAAAA TTTTTTAAGTCCGAGACGACCAAG 59
1 11 sense Y I 14 (10c)
39TTGTCGTTTATC TTTCAAATTTTTTTGTGATTCAAA 59* - antisense Y I 10 (8)
39GTCAATCGTCAA TATTTATCGGACCTTTTCCATTCA 59 14 sense Ya5 E 6 (4c)
39AGGAACCCTCAG TTTTTTGAACGACTACCATAAGAA 59
# 12 antisense Ya5 E 21 (16)
39AGGAACCCTCAG TTTTTTGAACGACTACCATAAGAA 59
# 17 antisense Ya5 E 21 (16)
39CCATAGTCAGTT ATTTTGGATTTCTTTCTTGTTTAT 59 13 antisense Ya5 E 22 (17)
39ACAAGAGAAGTG TTTTCTTCTTGTATACGCCGGAAA 59
{ 15 sense Ya5 E 33 (25)
39GTCCAAAACAAG TTCTTCACGCCATGGACGACTTAT 59 16 antisense Ya5 E 47 (38)
39CTTTGTGAAGTA TTTCGTCACGTTCCAACACCTCGT 59 10 sense Yb8 E 12 (10a)
39GGACTTAAAAAA TTTTTTCTCTTTCTGTTCCGGCCC 59
1 17 antisense Yb8 I 14 (10c)
39GTAAGCGGAGAA TTGTTACCAGAACACTTCCGAAAG 59 12 antisense Yb8 E 21 (16)
39TTCGATCGTAAC TTTGTTACTACAATTTAGACCAGT 59 14 sense Yb8 E 22 (17)
39ACAAGAGAAGTG TTTTCTTCTTGTATACGCCGGAAA 59
{ 15 sense Yb8 E 33 (25)
39GGACATGGGATG TTTTTTGTTTGTTTGTTTGTTTGT 59 16 antisense Yb8 I 48 (39)
39ACGTTAAGTTTA TTTTTGCTTTGACACAGTTAATCA 59 16 sense L1P1_orf2 E 23 (18)
39CATGGAAATTAA ATTTTTAGCTCCCGGTCAATGATC 59 13 sense LINE 1 E 39 (30)
39AATACGAATAAA TTCTTTTACCAAGTAACATCTAAG 59
39ACTTTAAATGAA TTCTTTATTGACACTAAACCGAAG 59
11
6
antisense
antisense
L1
T(n,120)
I 9 (7)
E 25 (19b)
AA-TTTT L1 endonuclease cleavage consensus site.
*This integration site cannot be unequivocally determined due to an associated 71-bp deletion and the lack of a TSD. The given integration site assumes either a model
where the second nick occurred downstream instead of upstream to the first nick that affected the NF1 sense strand or a model where the reverse transcribed Alu cDNA
strand (termed minus strand) invaded a double-strand break 71 bp downstream of the given integration site. Integration sites indicated with the same symbole 1, # or
{ are identical.
doi:10.1371/journal.pgen.1002371.t002
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three other genes, i.e APC, F9 and BTK, have been reported to be
used twice independently for L1 EN-mediated retrotransposon
insertions [24,39]. Taken together with our findings in the NF1
gene, a tenth (6/66) of the well characterized sites that harbor
disease causing retrotransposon insertions have been used multiple
times with half of them identified in the current study. It remains
to be elucidated which features make these sites particularly
vulnerable to L1 EN-mediated insertions. The fact that some of
these sites are embedded in a larger sequence context that appears
to be a hotspot region for insertions may indicate that flanking
sequences and possibly also the chromatin structure in these
regions may play a role.
It has been suggested that Alu and L1 elements have a similar
retrotransposition efficiency via-a `-vis the molecular retrotranspo-
sition machinery [40]. However, as in the NF1 gene also in
previously published disease causing retrotranspositional insertions
a preponderance of Alu over L1 insertions can be observed. As a
possible explanation Dewannieux et al. [3] propose that L1
elements harboring a disrupted ORF1, but retaining a functional
ORF2, should still be competent for trans mobilization of Alu
elements even if they are unable to promote their own
transposition. In other words, there appear to be more potential
‘‘drivers’’ for Alu retrotransposition than there are for L1
retrotransposition [4] potentially explaining the preponderance
of disease-causing Alu over L1 insertions [24].
18 novel Alu/L1 insertions substantially increase the
number of known disease-causing mutations of this type
With this report we substantially increase the number of known
disease causing Alu, L1 and simple poly(T) insertions. Hence, our
data confirm and extend several observations deduced from 48
previously analyzed pathological insertions [24]. All inserted
retrotransposons in our study contained a poly(A)/poly(T) tail
with a size in the range from 60–178 bp and all but one were
flanked by TSDs with a size in the range of 6–17 bp (see Table 1
and Table 2). All integration sites (Table 2) matched the previously
reported consensus sequence of the L1 EN cleavage site [13,41]
and there was no preferential orientation of the inserts with respect
to the NF1 coding sequence. All Alu insertions belong to the
evolutionary youngest ‘‘Y’’ Alu family (see Figure S4). Three of
them (MUI-2, UAB-R07118 and UAB-R869001 in Table 1)
lacked 17–39 bp at their 59 end when compared to the Alu
consensus sequence (Figure S4). According to [42] these three
elements would fall into the Group II Alu inserts which represent
,8% of all Alu elements polymorphic with respect to presence or
absence in the human genome. The poly(T) sequence inserted into
the NF1 exon 25 (19b) may represent a severely truncated Group
III Alu insertion [42]. Equally, this poly(T) stretch may result from
a severely truncated L1 element or even a processed pseudogene.
One AluY element inserted into intron 10 (8) was accompanied by
a 71-bp deletion and lacked a TSD. Different possible mechanisms
for the loss of genomic sequences in association with EN-
dependent retroelement insertions have been discussed [24].
One suggested mechanism depicted in Figure 6A in [33] assumes
that the second-strand nick at the top strand of the L1 target site is
made a few bp to the ‘‘left’’ of the initial nick on the bottom strand
rather than to the ‘‘right’’ causing the loss of a few bp at the
insertion site. A model that would explain the larger deletions of
several kb assumes that the reverse-transcribed cDNA strand of
the retroelement is involved in double-strand break processing and
invades a double-strand break to the ‘‘left’’ of the first-strand nick
(see Figure 6B in [33]). Both models may theoretically apply to the
71-bp deletion associated with the AluY insertion into NF1 intron
10 (8). In both models the first-strand L1 EN-mediated nick would
have occurred at position c.1186-85_1186-86 in intron 10 (8) (as
tentatively given in Table 1 and Table 2). However, it is also
possible that an EN-independent integration mechanism as
previously observed in certain Chinese hamster ovary (CHO) cell
models [41,43] has led to the TSD-lacking and deletion-associated
integration of this AluY element.
According to Kojima [44] L1 elements of the human genome
can be classified into three categories: full-length, 59-truncated and
59-inverted, comprising respectively 25.5%, 43.8% and 30.7% of
all L1 elements. Here we found an example of each category. The
full-length element belonging to the youngest L1(Ta-1d) subset was
a simple insertion in sense orientation with regard to the NF1
coding sequence flanked by a 12-bp TSD. The 59-truncated
element lacked the promoter region, the entire ORF1 and the first
2080 bp of the 3825-bp ORF2. Of note, this is only the second
reported pathogenic insertion of an older and less active L1(pre-
Ta) element [2]; the first was found in the F8 gene in a hemophilia
A patient [21]. The 59 inverted L1 element contained a poly(T) tail
at the 59 end but the analyzed sequence at the 39 end was inserted
in sense orientation and contained 1088 bp from the center of the
3825-bp ORF2 (Figure S6). This suggests that during the process
of retrotransposition the orientation of the reverse transcription
from the L1-RNA template that started at the sense strand of the
NF1 gene switched and continued from the anti-sense strand. The
presence of a 2-bp micro-homology that may have promoted
strand switching due to secondary binding between the RNA-
template and the 39-end of the 59-overhang at the antisense strand
supports the model of twin priming [45] (depicted also in Figure 1
in [44]) as the underlying mechanism leading to the insertion of
this 59 inverted L1 element.
Splicing defects are the prevalent effect of L1
EN-mediated retroelement insertions
Only four of the Alu insertions identified here directly affect
splice sites. Nevertheless, all L1 EN-mediated insertions in this
study affected NF1 splicing in the patients. The predominant
Figure 3. Schematic presentation of the splicing effects caused
by the identified Alu and L1 insertions. The affected exon is
indicated with a purple bar and the two flanking exons with blue bars.
Intronic sequences are indicated by black lines. Red triangles denote
the inserted Alu and L1 sequences and cryptic splice sites within an
exon or the retrotransposon are indicated by a dotted line. The
genomic sequence and the ensuing mRNA transcripts are depicted at
the left and right hand site, respectively.
doi:10.1371/journal.pgen.1002371.g003
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skipping (6/13 cases) or use of a cryptic splice site -either a cryptic
59 splice site upstream (3/13 cases) or a cryptic 39 splice site
downstream of the integration site (1/13 cases). In one of 13 cases
both of these splice effects were observed in the same patient.
In only two cases part of the Alu or L1 element were contained
in the mRNA transcripts, inserted into exon 12 (10a) and 39
(30) respectively. Overall, we do not believe that ascertainment
bias can explain why exon skipping and/or use of cryptic
splice site are the main effects of the de novo Alu and L1 insertions
in exonic sequences. Firstly, because we have no evidence
that the long-range RT-PCR reactions used in the applied assays
would miss Alu insertions in exons or introns that lead to
full or partial exonisation of the inserted sequences in the
mRNA transcripts. On the contrary, duplications of single or
multiple exons which lead to a similar size increase of the RT-
PCR products were readily detected by our assays [46]. Secondly,
in agreement with our observations, exon skipping was also
the reported effect of 5/7 L1 EN-mediated integrations for
which RNA data were available in the literature (see Table 1 in
[28]). Hence, following an exon definition model of splicing
[47], our data indicate that the main effect of exonic Alu and L1
insertion is weakening of the exon definition resulting in
altered splicing of the affected exon. Currently it is not
fully evaluated by which mechanisms the inserted sequences
reduce exon recognition by the splicing machinery. It has been
proposed that inserted sequences may disrupt specific cis-acting
exonic splice elements, such as exonic splicing enhancers
(ESEs) (see [28] and references cited therein). However, it is
unlikely this pertains to all or to the majority of exonic de novo
insertions. Therefore, we favor the hypothesis that the insertion of
a relatively large number of nucleotides (300–2000 bp) weakens
exon definition simply by increasing the size of the affected exon
and/or by disrupting the exonic structure of cis acting elements in
a more general sense, e.g. by increasing the distance of exonic cis
regulatory elements and the splice sites of the exon. In this respect
it is of note that the use of cryptic 59-a n d3 9- splice sites in exons
21 (16) and 25 (19b) is also observed in transcripts from mutant
NF1 alleles that carry single nucleotide alterations destroying the
respective natural 59-a n d3 9- splice sites of these exons ([48] and
Messiaen unpublished results). This observation may indicate that
some of the inserted sequences weaken particularly the down-
stream or upstream splice site while the definition of the
respective other splice site is unaffected which in certain instances
favors use of a cryptic splice over skipping of the affected exon
[48–49].
The integration of an inverted L1 element into intron 9 (7)
caused a complex splicing effect, i.e. insertion of a cryptic exon
embedded in the inserted L1 element and skipping of the
preceding exon 9 (7). A similar splicing defect was described in a
chronic granulomatous disease patient who carried a truncated L1
element in intron 5 of the CYBB gene [50]. As in the NF1 gene, the
cryptic exon inserted in the transcripts of CYBB was not better
defined by the splice sites compared to the flanking natural exons
that were skipped in those transcripts containing the L1 derived
cryptic exon. Hence, it remains to be explained why insertion of
these L1 elements lead to exonisation of the cryptic exon on the
account of the adjacent natural ones.
Concluding remarks
Our results clearly show that RNA-based mutation analysis
strategies have the potential to detect disease-causing L1 and Alu
insertions. In addition, the RNA-based comprehensive NF1
mutation detection approaches unambiguously identify and
functionally characterize other classes of mutations usually missed
by DNA-based mutation detection strategies, such as intronic
alterations outside the canonical splice site dinucleotides (GT-AG)
(including deep intronic mutations), as well as silent and missense
mutations with an effect on splicing [48,51]. Still this approach
may underestimate L1 EN-mediated insertions. De novo retro-
transposon insertions within the 39-o r5 9-UTR can lead to
reduced expression by the disruption of gene regulatory elements
[52–53]. Furthermore, insertion of L1 elements within introns has
been shown to reduce mRNA transcript levels. This phenomenon
is related to RNA polymerase II elongation defects and/or
premature polyadenylation caused by the L1 elements [54–55].
Thus, it is possible that insertions especially in the regulatory or
intronic regions of the gene may still be missed by the here applied
NF1 mutation analysis assay.
Material and Methods
Patients
All mutations reported were uncovered in samples from
unrelated index patients sent for clinical NF1 testing to two
centers, i.e. the Medical Genomics Laboratory at the University of
Alabama in Birmingham (UAB) and the Division of Human
Genetics, Medical University Innsbruck (MUI). Informed consent
was obtained from all patients. This study was approved by the
ethical committee from both institutions.
Identification of splicing defects by direct cDNA
sequencing
In both laboratories the primary assay for comprehensive NF1
mutation analysis is a direct cDNA sequencing approach that is
based on the amplification of the entire NF1 coding region in
three (Birmingham, AL) or five (Innsbruck) overlapping RT-PCR
fragments and subsequent sequencing of the entire PCR products
with 18 (20) internal primers. Details on the RT-PCR reactions
and primers can be found in [37,56]. To avoid illegitimate
splicing, known to lead to multiple aberrant splice variants
that impede the detection of mutations in an RNA-based
approach [51,57], total RNA is extracted from phytohemagglu-
tinin (PHA)-stimulated short-term lymphocyte cultures treated
with 200 mg/ml puromycin for 4 h prior to cell harvest to
prevent the nonsense-mediated RNA decay [51]. Details on
cell culture, RNA-extraction and cDNA synthesis can be found in
[37]. BigDye Terminator Cycle Sequencing chemistry was used
for sequencing (Applied Biosystems, Foster City, CA). The
sequencing reactions were subsequently run on an automated
capillary sequencer and analyzed using the sequence analysis
program SeqScape v2.5 (Applied Biosystems, Foster City, CA)
and/or SequencePilot (JSI Medical Systems, Kippenheim,
Germany). In some instances it was necessary to manually
analyze (read) the aberrant sequences in order to determine all
splicing defects deducible from multiple overlaying sequences (see
Figure S1).
NF1 nucleotide numbering is based on GenBank reference
sequence NM_000267.3 with the A of the ATG start codon being
nucleotide position c.1. The integration sites are given according
to the HGVS nomenclature after the first duplicated sequence
regardless of whether the first nick occurred at the sense or the
anti-sense strand and the thereof resulting orientation of the
insertion with respect to the NF1 coding sequence. Exons are
numbered according to the reference sequence with the widely
known legacy numbering given in parenthesis.
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insertions
Exons and flanking intronic sequences affected by splicing
defects were analyzed by sequencing from genomic DNA and by
multiplex ligation dependent probe amplification (MLPA) with the
current SALSA-MLPA-kit P081-B1 and/or P082-B1 (MRC-
Holland, Amsterdam, the Netherlands). When MLPA results were
negative for a genomic deletion of the respective exon and no
alteration was identified explaining the observed splicing defect,
sequences were meticulously reanalyzed to uncover a possible Alu/
L1 insertion within or in close vicinity of the exon (see Figure S2).
To diminish allelic drop-out of the mutant allele due to the
increased exon size by an Alu/L1 insertion, the PCR conditions
were modified to allow for the amplification of larger sequences
from gDNA of the patients. Primers and PCR conditions used to
amplify the affected exons are listed in Table S1A and S1B.
Mutant exons containing Alu elements were amplified using
Takara Ex Taq (Takara Biotechnology Co. LTD, Madison, WI)
or Taq DNA Polymerase (Invitrogen, Carlsbad, CA). To amplify
the mutant alleles containing a truncated 1753-bp and a full-length
6-kb L1 element, respectively, Expand Long PCR Taq (Roche
Diagnostics GmbH, Roche Applied Science, Mannheim, Ger-
many) was used. To determine the precise sequence of the inserted
Alu element as well as the duplicated sequence at the insertion site
the PCR products showing a band of increased size were cloned
according to the manufacturer’s instructions into the TOPO-TA
cloning vector pCR 4-TOPO (Invitrogen, Carlsbad, CA) and
individually sequenced. Alternatively or in addition, primers were
designed to specifically amplify only the mutant alleles containing
the Alu insertions. These primers contained at their 59-end the
exonic sequences immediately upstream/downstream of the
insertion site and at the 39-end a few nucleotides of either the
Alu or the poly(A/T) stretch. All primers are listed in Table S1A.
PCR products generated with these primers used together with the
regular exon primer at the opposite site of the exon were
subsequently sequenced (see as an example Figure S3). Alignment
of the identified Alu sequences with the consensus sequences of the
different Alu families (as deposited in Repbase Giri [29]) was
performed with the program ClustalW v.1.83 [58]. To amplify the
much larger mutant alleles containing a truncated 1753-bp and a
full-length 6-kb L1 element, the Expand Long PCR Taq kit
(Roche Diagnostics GmbH, Roche Applied Science, Mannheim,
Germany) specifically designed to amplify fragments up to around
20 kb, was used. To sequence the 59-end of a full length L1
element integrated in exon 39 (30) a L1-specific reverse primer
(L1-5_39r in Table S1) was used together with the exon 39 (30)
forward primer (39f). Thereafter, the entire 6021-bp L1 sequence
was characterized by sequencing of the PCR product generated
with primers 39f and 39r (Figure 2) using L1-sequence specific
internal primers (Table S1). Similarly, to amplify a mutant 1800-
bp fragment containing a truncated L1 element in exon 23 (18),
and thereafter sequence the 59 and 39ends of this mutant fragment,
we used the primers 23f and 23r. In addition, sequence analysis
was performed with a L1-specific primer, L1_Fam (Table S1),
located 86 bp upstream of a 3-bp diagnostic site that distinguishes
the young L1 subfamilies (Ta) and pre-(Ta) from the older ones
[35]. To determine the sequence inserted into intron 9 (7) that
lead, at the transcript level, to loss of exon 9 (7) and concomitant
insertion of an L1-derived 130-bp sequence between exons 8 (6)
and 10 (8) in patient UAB-R91409, a reverse and a forward
primer (Line9_r and Line10_f in Table S1) were used in two PCR
reactions together with the exon 9 (7) forward (9f) and the exon 10
(8) reverse (10r) primer, respectively. The resulting PCR products
were sequenced in both directions.
Supporting Information
Figure S1 Detection of two aberrant splice products due to an
AluYa5 insertion in exon 47 (38). The sequence generated with a
reverse primer from a RT-PCR product from the patient shows
the border of NF1 exons 47 (38) and 48 (39). In addition to the wild
type transcript two aberrantly spliced transcripts can be deduced
from the sequence. One aberrant transcript lacks the entire exon
47 (38) and the other the last 62 nucleotides of exon 47 (38) due to
the use of an exonic cryptic 59-splice site upstream of the
integration site.
(TIF)
Figure S2 Detection of an AluYa5 insertion in NF1 exon 47 (38).
A) Agarose gel showing PCR products generated from gDNA
from a control individual (C) and the patient (P) harboring an
AluYa5 insertion in NF1 exon 47 (38), (W=water, M=size
Marker). PCR product of the patient shows a faint extra band of
larger size (arrow) that is not present in the control. B) Sequences
of the PCR products from the control individual and the patient.
The sequence of the patient shows a faint background sequence (a
poly(T) stretch) starting at nucleotide c.6952 (vertical dotted line).
This indicates the insertion of a retrotransposon, in this case an
AluYa5 element, in anti-sense direction with respect to the NF1
coding sequence at this site.
(TIF)
Figure S3 Specific PCR for the AluYa5 insertion in NF1 exon 47
(38). A) Scheme showing the strategy to amplify the AluYa5
insertion. Exons are shown as boxes and introns as lines. The Alu-
insertion is shown as an arrow in anti-sense orientation. In order to
specifically amplify the mutant allele containing the Alu sequence
two Alu insertion specific primers (Alu_47f and Alu_47r) spanning
the exon 47 (38)-Alu insertion border were designed. These
primers were used together with their respective regular exon
primer (47r or 47f) at the opposite site of the exon resulting in
fragments of 600 bp and 1000 bp, respectively, each containing
the Alu insertion. C) Agarose gel showing the result of the Alu-
insertion specific PCRs derived from the patient (P) and a control
individual (C). B) Sequence analysis of the specific Alu-insertion
product generated by the Alu insertion-specific reversed primer
and the respective regular forward primer, shows the anti-sense
orientation of the Alu insertion.
(TIF)
Figure S4 Sequence alignment of the 14 Alu sequences with the
consensus sequence of the AluY, AluYa5 and AluYb8 subfamilies.
Identical nucleotides between all sequences are indicated by
capital letters. In order to maximize the alignment gaps were
introduced (dashed). The reference sequences of the Alu
subfamilies were taken from Repbase Giri [29].
(TIF)
Figure S5 Alignment of the full length L1 sequence with the
consensus sequence of the hot L1 element. The element was found
inserted in sense orientation into the NF1 exon 39 (30) of a patient
(R01429). The sequence of the hot L1 element is taken from [2].
Ten deviations from the consensus sequence, two of which in the
ORF1 and five in ORF2 (six of them altering the amino acid code)
are highlighted by light background.
(TIF)
Figure S6 Truncated L1 element inserted into intron 9 (7).
Genomic sequence of intron (IVS) 9 (7) (black letters) with
truncated L1 element (green letters) inserted at position
c.1062+195_1062+196 and the flanking exons 9 (7) and 10 (8)
(red letters). The inserted sequence contains at the 59-end a poly(T)
Hotspots for Retroelement Insertions in NF1 Gene
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annealed to the sense strand where reverse transcription from the
template started. However, the 39-end of the inserted sequence
contains in sense orientation with regard to the NF1 coding
sequence at least 1088 bp from the center of the L1 ORF2 and
ends with the 3167
th nucleotide of the 3825-bp L1 ORF2
suggesting that during the process of retrotransposition the
orientation of the reverse transcription from the L1-RNA template
that started at the sense strand of the NF1 gene switched and
continued from the anti-sense strand. The duplicated nucleotides
of the TSD are underlined. The 130-bp cryptic exon embedded in
the L1 element is indicated in a darker shade of green. The
sequence used to design L1 insertion-specific primers is under-
lined. The splices site scores of the cryptic exon as calculated by
Splice Site Prediction by Neural Net (http://www.fruitfly.org/
seq_tools/splice.html) is 0.62 for the 59 splice site and 0.86 for the
39 splice site.
(TIF)
Table S1 (A) List of primers for amplification of NF1 exons, Alu
and L1 sequences. (B) List of PCR programs.
(PDF)
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